Skip to main content
SpringerLink
Log in

Collaborative Matrix Factorization with Soft Regularization for Drug-Target Interaction Prediction

  • Regular Paper
  • Published:
Journal of Computer Science and Technology Aims and scope Submit manuscript

Abstract

Identifying the potential drug-target interactions (DTI) is critical in drug discovery. The drug-target interaction prediction methods based on collaborative filtering have demonstrated attractive prediction performance. However, many corresponding models cannot accurately express the relationship between similarity features and DTI features. In order to rationally represent the correlation, we propose a novel matrix factorization method, so-called collaborative matrix factorization with soft regularization (SRCMF). SRCMF improves the prediction performance by combining the drug and the target similarity information with matrix factorization. In contrast to general collaborative matrix factorization, the fundamental idea of SRCMF is to make the similarity features and the potential features of DTI approximate, not identical. Specifically, SRCMF obtains low-rank feature representations of drug similarity and target similarity, and then uses a soft regularization term to constrain the approximation between drug (target) similarity features and drug (target) potential features of DTI. To comprehensively evaluate the prediction performance of SRCMF, we conduct cross-validation experiments under three different settings. In terms of the area under the precision-recall curve (AUPR), SRCMF achieves better prediction results than six state-of-the-art methods. Besides, under different noise levels of similarity data, the prediction performance of SRCMF is much better than that of collaborative matrix factorization. In conclusion, SRCMF is robust leading to performance improvement in drug-target interaction prediction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morgan S, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: A systematic review. Health Policy, 2011, 100(1): 4-17. https://doi.org/10.1016/j.healthpol.2010.12.002.

    Article  Google Scholar 

  2. Pushpakom S P, Iorio F, Eyers P A et al. Drug repurposing: Progress, challenges and recommendations. Nature Reviews Drug Discovery, 2019, 18(1): 41-58. https://doi.org/10.1038/nrd.2018.168.

    Article  Google Scholar 

  3. Drews J. Drug discovery: A historical perspective. Science, 2000, 287(5460): 1960-1964. https://doi.org/10.1126/science.287.5460.1960.

    Article  Google Scholar 

  4. Mohs R C, Greig N H. Drug discovery and development: Role of basic biological research. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2017, 3(4): 651-657. https://doi.org/10.1016/j.trci.2017.10.005.

  5. Wang Y, Bryant S H, Cheng T, Wang J, Gindulyte A, Shoemaker B, Thiessen P, He S, Zhang J. PubChem BioAssay: 2017 update. Nucleic Acids Research, 2017, 45(D1): D955-D963. https://doi.org/10.1093/nar/gkw1118.

  6. Whitebread S, Hamon J, Bojanic D, Urban L. Keynote review: in vitro safety pharmacology profiling: An essential tool for successful drug development. Drug Discovery Today, 2005, 10(21): 1421-1433. https://doi.org/10.1016/S1359-6446(05)03632-9.

    Article  Google Scholar 

  7. Keiser M, Roth B, Armbruster N, Ernsberger P, Irwin J, Shoichet B. Relating protein pharmacology by ligand chemistry. Nature Biotechnology, 2007, 25(2): 197-206. https://doi.org/10.1038/nbt1284.

    Article  Google Scholar 

  8. Li H, Gao Z, Kang L, Zhang H. TarFisDock: A web server for identifying drug targets with docking approach. Nucleic Acids Research, 2006, 34(2): W219-W224. https://doi.org/10.1093/nar/gkl114.

    Article  Google Scholar 

  9. Ezzat A, Wu M, Li X, Kwoh C. Computational prediction of drug-target interactions using chemogenomic approaches: An empirical survey. Briefings in Bioinformatics, 2019, 20(4): 1337-1357. https://doi.org/10.1093/bib/bby002.

    Article  Google Scholar 

  10. Bleakley K, Yamanishi Y. Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics, 2009, 25(18): 2397-2403. https://doi.org/10.1093/bioinformatics/btp433.

    Article  Google Scholar 

  11. Mei J, Kwoh C, Yang P, Li X, Zheng J. Drug-target interaction prediction by learning from local information and neighbors. Bioinformatics, 2013, 29(2): 238-245. https://doi.org/10.1093/bioinformatics/bts670.

    Article  Google Scholar 

  12. Twan V, Elena M, Peter C. Predicting drug-target interactions for new drug compounds using a weighted nearest neighbor profile. PLoS ONE, 2013, 8(6): Article No. e66952. https://doi.org/10.1371/journal.pone.0066952.

  13. Yan C, Wang J, Lan W et al. SDTRLS: Predicting drug-target interactions for complex diseases based on chemical substructures. Complexity, 2017, 2017: Article No. 2713280. https://doi.org/10.1155/2017/2713280.

  14. Wang W, Yang S, Li J. Drug target predictions based on heterogeneous graph inference. In Proc. the 2013 Pacific Symposium on Biocomputing, January 2013, pp.53-64. https://doi.org/10.1142/9789814447973_0006.

  15. Wang L, You Z, Chen X. RFDT: A rotation forest-based predictor for predicting drug-target interactions using drug structure and protein sequence information. Current Protein and Peptide Science, 2018, 19(5): 445-454. https://doi.org/10.2174/1389203718666161114111656.

    Article  Google Scholar 

  16. Olayan R, Ashoor H, Bajic V. DDR: Efficient computational method to predict drug-target interactions using graph mining and machine learning approaches. Bioinformatics, 2018, 34(7): 1164-1173. https://doi.org/10.1093/bioinformatics/btx731.

    Article  Google Scholar 

  17. Huang Y, You Z, Chen X. A systematic prediction of drug-target interactions using molecular fingerprints and protein sequences. Current Protein and Peptide Science, 2018, 19(5): 468-478. https://doi.org/10.2174/1389203718666161122103057.

    Article  Google Scholar 

  18. Yang M, Li Y, Wang J. Feature and nuclear norm minimization for matrix completion. IEEE Transactions on Knowledge and Data Engineering. https://doi.org/10.1109/TKDE.2020.3005978.

  19. Yang M, Luo H, Li Y, Wu F X, Wang J. Overlap matrix completion for predicting drug-associated indications. PLoS Computational Biology, 2019, 15(12): Article No. e1007541. https://doi.org/10.1371/journal.pcbi.1007541.

  20. Yang M, Luo H, Li Y, Wang J. Drug repositioning based on bounded nuclear norm regularization. Bioinformatics, 2019, 35(14): i455-i463. https://doi.org/10.1093/bioinformatics/btz331.

    Article  Google Scholar 

  21. Gönen M. Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization. Bioinformatics, 2012, 28(18): 2304-2310. https://doi.org/10.1093/bioinformatics/bts360.

    Article  Google Scholar 

  22. Zheng X, Ding H, Mamitsuka H, Zhu S. Collaborative matrix factorization with multiple similarities for predicting drug-target interactions. In Proc. the 19th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, August 2013, pp.1025-1033. https://doi.org/10.1145/2487575.2487670.

  23. Liu Y, Wu M, Miao C, Zhao P, Li X. Neighborhood regularized logistic matrix factorization for drug-target interaction prediction. PLoS Computational Biology, 2016, 12(2): Article No. e1004760. https://doi.org/10.1371/journal.pcbi.1004760.

  24. Ezzat A, Zhao P, Wu M, Li X, Kwoh C. Drug-target interaction prediction with graph regularized matrix factorization. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2016, 14(3): 646-656. https://doi.org/10.1109/TCBB.2016.2530062.

    Article  Google Scholar 

  25. Mohamed S, Nováek V, Nounu A. Discovering protein drug targets using knowledge graph embeddings. Bioinformatics, 2020, 36(2): 603-610. https://doi.org/10.1093/bioinformatics/btz600.

    Article  Google Scholar 

  26. Thafar M, Olayan R, Ashoor H et al. DTiGEMS+: Drug-target interaction prediction using graph embedding, graph mining, and similarity-based techniques. Journal of Cheminformatics, 2020, 12(1): Article No. 44. https://doi.org/10.1186/s13321-020-00447-2.

  27. Wang B, Mezlini A, Demir F et al. Similarity network fusion for aggregating data types on a genomic scale. Nature Methods, 2014, 11(3): 333-337. https://doi.org/10.1038/nmeth.2810.

    Article  Google Scholar 

  28. Yang M, Wu G, Zhao Q, Li Y, Wang J. Computational drug repositioning based on multi-similarities bilinear matrix factorization. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaa267.

  29. Zhang L, Zhang S. A general joint matrix factorization framework for data integration and its systematic algorithmic exploration. IEEE Transactions on Fuzzy Systems, 2020, 28(9): 1971-1983. https://doi.org/10.1109/TFUZZ.2019.2928518.

    Article  Google Scholar 

  30. Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 2008, 24(13): i232-i240. https://doi.org/10.1093/bioinformatics/btn162.

    Article  Google Scholar 

  31. Kanehisa M, Goto S, Hattori M, Aoki-Knoshita K, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Research, 2006, 34: D354-D357. https://doi.org/10.1093/nar/gkj102.

  32. Schomburg I, Chang A, Ebeling C et al. BRENDA, the enzyme database: Updates and major new developments. Nucleic Acids Research, 2004, 32(suppl 1): D431-D433. https://doi.org/10.1093/nar/gkh081.

  33. Günther S, Kuhn M, Dunkel M et al. SuperTarget and matador: Resources for exploring drug-target relationships. Nucleic Acids Research, 2008, 36(suppl 1): D919-D922. https://doi.org/10.1093/nar/gkm862.

  34. Wishart D, Knox C, Guo A, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research, 2008, 36(suppl 1): D901-D906. https://doi.org/10.1093/nar/gkm958.

  35. Hattori M, Okuno Y, Goto S, Kanehisa M. Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. Journal of the American Chemical Society, 2003, 125(39): 11853-11865. https://doi.org/10.1021/ja036030u.

    Article  Google Scholar 

  36. Gaulton A, Bellis L J, Bento A P et al. ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Research, 2012, 40(D1): D1100-D1107. https://doi.org/10.1093/nar/gkr777.

  37. Sayers E W, Agarwala R, Bolton E E et al. Database resources of the national center for biotechnology information. Nucleic Acids Research, 2019, 47(D1): D23-D28. https://doi.org/10.1093/nar/gky1069.

  38. Gürgen S G, Yazıcı G N, Gözükara C et al. Metoclopramide use to induce lactation can alter BDNF and DRD2 in the prefrontal cortex of offspring. Journal of Chemical Neuroanatomy, 2020, 109: Article No. 101844. https://doi.org/10.1016/j.jchemneu.2020.101844.

  39. Naveen M, Patil A N, Pattanaik S et al. ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients. Asian Journal of Psychiatry, 2020, 48: Article No. 101918. https://doi.org/10.1016/j.ajp.2019.101918.

Download references

Author information

Authors and Affiliations

  1. School of Computer Science and Engineering, Central South University, Changsha, 410083, China

    Li-Gang Gao, Meng-Yun Yang & Jian-Xin Wang

  2. Hunan Provincial Key Laboratory of Bioinformatics, Central South University, Changsha, 410083, China

    Li-Gang Gao, Meng-Yun Yang & Jian-Xin Wang

  3. School of Science, Shaoyang University, Shaoyang, 422000, China

    Meng-Yun Yang

Authors
  1. Li-Gang Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meng-Yun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian-Xin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian-Xin Wang.

Supplementary Information

ESM 1

(PDF 273 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, LG., Yang, MY. & Wang, JX. Collaborative Matrix Factorization with Soft Regularization for Drug-Target Interaction Prediction. J. Comput. Sci. Technol. 36, 310–322 (2021). https://doi.org/10.1007/s11390-021-0844-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11390-021-0844-8

Keywords

Search

Navigation